JCO® Precision Oncology (JCO PO) publishes study demonstrating clinical validity and utility of OncoHost’s PROphet® NSCLC Test
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced the publication of a study in JCO® Precision Oncology (JCO PO) demonstrating the clinical validity and utility of its proprietary PROphet® NSCLC test. Read...
Read More